New Study Suggests Male Circumcision Curbs HIV Among MSM – Calls For Policy Action 22/03/2019 David Branigan The largest and most comprehensive study to date of the HIV prevention benefits of male circumcision for men who have sex with men (MSM) found that circumcision reduced the odds of HIV infection among this group by 42 percent in low- and middle-income countries, and overall by 23 percent. Image Credits: Avert/Gil Eilam/CC BY-NC-ND 2.0. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB 13/02/2019 David Branigan Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading -> Posts navigation Newer posts